<DOC>
	<DOCNO>NCT01167062</DOCNO>
	<brief_summary>This randomize double blind placebo-controlled study ass efficacy Tamsulosin oral-controlled absorption system ( OCAS ) 0.4 mg conjunctive medical treatment distal ureteral stone size 4-10 mm compare placebo control group .</brief_summary>
	<brief_title>Efficacy Tamsulosin Oral-controlled Absorption System ( OCAS ) Treatment Distal Ureteral Stones</brief_title>
	<detailed_description>- patient randomize receive placebo Tamsulosin OCAS 0.4 mg 1 tablet OD maximum 28 day ureteral stone pass sodium diclofenac 50 mg twice day , 10 day . - All patient receive 75 mg sodium diclofenac via intramuscular demand</detailed_description>
	<mesh_term>Calculi</mesh_term>
	<mesh_term>Ureteral Calculi</mesh_term>
	<mesh_term>Ureterolithiasis</mesh_term>
	<mesh_term>Tamsulosin</mesh_term>
	<criteria>Male female patient age = &gt; 18 year . Patients distal ureteral stone size 410 mm Written inform consent obtain . Patients history ureteral surgery Patients urinary tract infection Patient diabetes peptic ulcer Patient renal dysfunction ( elevate serum creatinine level ) Patients severe hydronephrosis Patients history pass stone Pregnancy Patients desire withdraw study</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>June 2010</verification_date>
</DOC>